Page last updated: 2024-08-16
vorinostat and fk 866
vorinostat has been researched along with fk 866 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Chen, W; Dong, G; Miao, C; Rao, Y; Sheng, C; Wang, P; Wang, X; Xu, T; Yang, X; Zhang, W | 1 |
| Chen, W; Dong, G; Miao, C; Sheng, C; Wu, Y; Zhang, W | 1 |
| Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
Other Studies
3 other study(ies) available for vorinostat and fk 866
| Article | Year |
|---|---|
Small Molecule Inhibitors Simultaneously Targeting Cancer Metabolism and Epigenetics: Discovery of Novel Nicotinamide Phosphoribosyltransferase (NAMPT) and Histone Deacetylase (HDAC) Dual Inhibitors.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Drug Discovery; Enzyme Inhibitors; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Male; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasms; Nicotinamide Phosphoribosyltransferase; Small Molecule Libraries; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2017 |
Dual NAMPT/HDAC Inhibitors as a New Strategy for Multitargeting Antitumor Drug Discovery.
Topics: | 2018 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |